Users Coming Off Weight-Loss Injections Gain Back Weight Far More Rapidly Compared to People Using Diet and Exercise

Fresh analysis indicates that individuals who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who stop traditional lifestyle plans.

Research printed in a leading medical journal points out that while obese people frequently drop about a fifth of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Individuals buying such drugs must be aware of the danger of fast weight regain when the treatment is stopped," cautioned expert Dr. Susan Jebb.

That rate of recovery implies a return to pre-treatment weight within about 18 months.

Comparing Treatments

The study, which reviewed 37 of trials involving thousands of participants, compared the effects of GLP-1 agonists with other pills.

Scientists emphasize that people who shed pounds through diet and exercise usually have a more gradual creep back—approximately 0.1 kg a month—once they finish.

Explaining the Quick Regain

Experts propose the mode of action of the injections explains the amplified weight return.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of the hormone levels several times higher than the body's typical production could lead to the system to produce less of its own natural hormone, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.

"Stopping of this hormone supplement means appetite is uncontrolled, making binge eating much more probable."

An Ongoing Disease?

The NHS advise the jabs for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.

Many experts say that, given the significant potential of weight regain, the therapy should be considered long-term.

This perspective is supported by pharmaceutical companies, who note that the results "highlight the long-term nature of excess weight," comparing it to managing conditions like hypertension.

User Testimonies

Individuals who have discontinued the medication explain a intense return of appetite.

"I experienced a switch flipping and you're instantly ravenous," recalled one woman.

The struggle is compounded if individuals have not established sustainable lifestyle or habit modifications during therapy.

Significant Adoption

Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest remaining high.

• Adoption is more common among females compared to males.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion obtain the medications through private prescriptions rather than public health services.

In conclusion, experts stress that while the jabs are effective tools for shedding pounds, they are not a standalone solution and long-term success likely depends on integrated behavioural changes.